Risk of Major Adverse Cardiovascular Events in Immune-Mediated Inflammatory Disorders on Biologics and Small Molecules: Network Meta-Analysis

By sjmartinez • October 12, 2023

Mattay SS, Zamani M, Saturno D, Loftus EV Jr, Ciorba MA, Yarur A, Singh S, Deepak P. Risk of Major Adverse Cardiovascular Events in Immune-Mediated Inflammatory Disorders on Biologics and Small Molecules: Network Meta-Analysis. Clin Gastroenterol Hepatol. 2023 Oct 9:S1542-3565(23)00767-X. doi: 10.1016/j.cgh.2023.09.033. Epub ahead of print. PMID: 37821035.

Tags: anti-TNF, cardiovascular disease, Cedars Sinai DoM, Digestive Diseases, Inflammation, inflammatory bowel disease, JAKi, Publications, ustekinumab

A phase 1 safety and feasibility trial of a ketogenic diet plus standard of care for patients with recently diagnosed glioblastoma

Amaral LJ, Gresham G, Kim S, Tighiouart M, Nelson TA, Welborn A, Lockshon L, Noorvash B, Rudnick JD, Irwin SA, Freedland SJ, Hu J. A[...]

Impact and management of warm autoimmune haemolytic anaemia associated with systemic lupus erythematosus

Pons-Estel GJ, Mosca M, Wallace DJ, Zazzetti F, Leon A, Noël W, Pierce A, Ebrahim T, Murakhovskaya I. Impact and management of warm autoimmune haemolytic[...]

Sudden cardiac arrest: Limitations in risk-stratification and treatment, and the potential for digital technologies and artificial intelligence to improve prediction and outcomes

Srivats S, Zghyer F, Shahrori Z, Albert C, Al-Khatib SM, Chugh S, Etheridge SP, Goldberger ZD, Gopinathannair R, Lakkireddy D, Morin DP, Perez MV, Rottmann[...]